Grifols (GRFS) Debt Ratio (2010 - 2025)
Grifols (GRFS) reported Debt Ratio of 0.46 for Q4 2025, up 4.01% on a YoY basis from 0.44 in Q4 2024, and up 4.01% quarter-over-quarter from 0.44 in Q4 2024.
Grifols (GRFS) Debt Ratio (2010 - 2025) Analysis & Trends
Grifols has reported Debt Ratio for 16 years, with the latest figure at 0.46 in Q4 2025.
- For the quarter ending Q4 2025, Debt Ratio rose 4.01% year-over-year to 0.46; the trailing twelve-month figure through Dec 2025 stood at 0.46 (up 4.01% YoY), and the FY2025 full-year result was 0.46, down 99.63% from the prior year.
- Debt Ratio for Q4 2025 stood at 0.46, up from 0.44 in the prior quarter.
- The five-year high for Debt Ratio was 0.48 in Q4 2022, with the low at 0.04 in Q4 2023.
- Historically, Debt Ratio has averaged 0.37 across 5 years, with a median of 0.44 in 2024.
- Annual changes were most pronounced in 2023 — Debt Ratio slumped 90.77% — and 2024, when it jumped 901.24%.
- Grifols' Debt Ratio stood at 0.41 in 2021, then grew by 18.15% to 0.48 in 2022, then tumbled by 90.77% to 0.04 in 2023, then jumped by 901.24% to 0.44 in 2024, then climbed by 4.01% to 0.46 in 2025.
- The last three Debt Ratio figures came in at 0.46 (Q4 2025), 0.44 (Q4 2024), and 0.04 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | -0.22 |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 0.37 |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 0.27 |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 0.47 |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 0.38 |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 0.62 |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 0.39 |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 0.31 |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 0.51 |
| 10 | Grifols | 6.05 Bn | 5.09 Bn | - | 0.46 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.46 |
| Dec 31, 2024 | 0.44 |
| Dec 31, 2023 | 0.04 |
| Dec 31, 2022 | 0.48 |
| Dec 31, 2021 | 0.41 |
| Dec 31, 2020 | 0.46 |
| Sep 30, 2020 | 0.45 |
| Mar 31, 2020 | 0.45 |
| Dec 31, 2019 | 0.01 |
| Sep 30, 2019 | 0.52 |
| Dec 31, 2018 | 0.01 |
| Sep 30, 2018 | 0.54 |
| Jun 30, 2018 | 0.54 |
| Mar 31, 2018 | 0.54 |
| Dec 31, 2017 | 0.54 |
| Jun 30, 2017 | 0.56 |
| Dec 31, 2016 | 0.01 |
| Sep 30, 2016 | 0.49 |
| Jun 30, 2016 | 0.50 |
| Mar 31, 2016 | 0.00 |